IP Library Granted Patent US 7,717,948
Granted Patent B2
US 7,717,948 · App. 11/840,142 · Granted May 18, 2010

Methods and apparatus for thermally-induced renal neuromodulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,717,948
App. No.
11/840,142
Granted
May 18, 2010
Kind
B2
Abstract

Methods and apparatus are provided for thermally-induced renal neuromodulation. Thermally-induced renal neuromodulation may be achieved via direct and/or via indirect application of thermal energy to heat or cool neural fibers that contribute to renal function, or of vascular structures that feed or perfuse the neural fibers. In some embodiments, parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermally-induced neuromodulation. In some embodiments, protective elements may be provided to reduce a degree of thermal damage induced in the non-target tissues.

Claims (30)

1. A method of treating a human patient diagnosed with a cardio-renal disease or disorder, the method comprising:

delivering a device to a vicinity of a neural fiber associated with renal function; and

thermally inhibiting neural communication along the neural fiber with the device.

2. The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises thermally inhibiting afferent neural communication along the neural fiber with the device.

3. The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises thermally inhibiting efferent neural communication along the neural fiber with the device.

4. The method of claim 1 wherein delivering a device to a vicinity of a neural fiber associated with renal function comprises delivering the device via a blood vessel to a position proximate to the neural fiber.

5. The method of claim 4 wherein delivering the device via a blood vessel to a position proximate to the neural fiber comprises delivering the device via a renal blood vessel to a position proximate to the neural fiber.

6. The method of claim 4 wherein delivering the device via a blood vessel to a position proximate to the neural fiber comprises positioning the device in contact with a wall of the blood vessel proximate to the neural fiber.

7. The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises at least partially ablating the neural fiber with the device.

8. The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises thermally altering the neural fiber using at least one of non-ablative heating, ablative heating, cooling, and freezing.

9. The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises administering a thermal stimuli to the neural fiber for a period of time no less than about 30 seconds to no greater than about 10 minutes.

10. The method of claim 1 , further comprising removing the device from the patient after thermally inhibiting neural communication along the neural fiber.

11. The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises delivering an energy field to the neural fiber via the device.

12. The method of claim 11 wherein delivering an energy field to the neural fiber via the device comprises delivering radiofrequency energy via the device.

13. The method of claim 11 wherein delivering an energy field to the neural fiber via the device comprises delivering microwave energy via the device.

14. The method of claim 11 wherein delivering an energy field to the neural fiber via the device comprises delivering ultrasound energy via the device.

15. The method of claim 14 wherein delivering ultrasound energy via the device comprises delivering high intensity focused ultrasound energy via the device.

16. The method of claim 11 wherein delivering an energy field to the neural fiber via the device comprises delivering laser energy via the device.

17. The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises reducing neural activity via cooling the neural fiber.

18. The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises causing freezing injury to the neural fiber.

19. The method of claim 1 wherein thermally inhibiting neural communication along the neural fiber with the device comprises delivering a thermal fluid via the device.

20. A method of treating a human patient diagnosed with a medical condition, the method comprising:

positioning a device in proximity to a neural pathway that carries nerve signals to and from a kidney of the patient; and

thermally inhibiting the nerve signals across the neural pathway with the device.

21. The method of claim 20 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with hypertension.

22. The method of claim 20 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with heart failure.

23. The method of claim 20 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with a condition associated with diabetes.

24. The method of claim 20 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with kidney disease.

25. The method of claim 20 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with chronic renal failure.

26. The method of claim 20 wherein treating a human patient diagnosed with a medical condition comprises treating a human patient diagnosed with acute myocardial infarction.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2013
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 030285/0723 →
CHANGE OF NAME Recorded Apr 25, 2013
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 030293/0781 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2010
From: DEMARAIS, DENISE; ZADNO, NICOLAS; CLARK, BENJAMIN J.; THAI, ERIK; LEVIN, HOWARD R.; GELFAND, MARK
To: ARDIAN, INC.
Reel/Frame 024668/0235 →